The Michael J. Fox Foundation for Parkinson's Research
  Research
  News & Events
  Funding Programs
  About

PD Online Research

Alzheimer Research Forum
  Current Papers
  ARF Recommends
  Research News
PDGene - Gene overview of all published PD-association studies for PM20D1
Back Search Methods Disclaimer Credits
 Gene: PM20D1  (PARK16; FLJ32569; Cps1)  Entrez Gene
 Protein: peptidase M20 domain containing 1   ProteinLink
 Chromosome: 1   (View: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  X  Y  MT)
 Status: Updated 2 October 2011 ;  ***Note that in addition to PM20D1, the genes NUCKS1, SLC41A1, and SLC45A3 in PARK16 show genome-wide significant effects in PDGene. As statistical significance is currently weaker than for PM20D1, they are not listed in the top results, but can be accessed via the PDGene search function.***
Meta-Analysis
1. Case-Control Studies (by ethnic group)
      PD Cases Normal Controls  
Study Population Source # Polys # Subjects
(% women)
DX Onset Age
(range)
Age
(range)
# Subjects
(% women)
Age
(range)
Result
 Caucasian
Pankratz, 2008
USA (PROGENI, GenePD) CL  1  (detail)  857
(41%)
C61.9 + 10.8
(-)
-867
(60%)
54.8 + 13.1
(-)
Negative
Simon-Sanchez, 2009
USA, Germany (GWAS) CL,PO  1  (detail)  1745
(45%)
C55.8
(7-98)
-4047
(50%)
-Positive
Simon-Sanchez, 2009
USA, Germany, UK (Stage II) CL,PO  1  (detail)  2816
(-)
M--3401
(-)
-Negative
Simon-Sanchez, 2011
Netherlands (GWAS) CL,PO  1  (detail)  772
(36%)
U55.3
(16-84)
62.3
(29-89)
2024
(56%)
53.7
(45-95)
Negative
 Asian
Satake, 2009
Japan (Replication-2) CL  1  (detail)  321
(55%)
C63.7 + 9.7
(-)
-1614
(55%)
59.1 + 19.1
(-)
Positive
Satake, 2009
Japan (Replication-1) CL  1  (detail)  612
(50%)
C43 + 13.8
(20-80)
-14139
(42%)
60.1 + 12.6
(-)
Positive
Satake, 2009
Japan (GWAS) CL  1  (detail)  1078
(55%)
C-58.8 + 10.1
(22-88)
2628
(45%)
49.9 + 14.2
(-)
Positive
Tan, 2010
Singapore CL  1  (detail)  433
(44%)
C60
(-)
64
(-)
916
(40%)
56
(-)
Positive
Yan, 2011
China CL  1  (detail)  226
(45%)
C51.8 + 13.2
(9-83)
58.6
(-)
230
(46%)
-Positive
Contact us if you are an author of an association study regarding this gene and do not find your study in this table or find errors in the representation of your study details.
Source:  Source of case population -> “CL” (clinic-based), “PO” (population-based), or “CO” (community-based).
# Polys:  Number of polymorphisms tested per gene and per sample.
Onset Age and Age:  Mean or median age at onset or examination, respectively.
DX:  Criteria used to determine PD diagnosis ->  "C" (clinical PD diagnosis), "N" (neuropathological PD diagnosis), "M" (mixed, i.e. PD sample contains both clinical and neuropathological cases), "U" (unknown).
Result:  Overall conclusion reached by authors of the original publication (“positive” usually indicates significant (P<0.05) association in at least one of the performed analyses, and “negative” indicates no evidence for significant association, while “trend” indicates results in between).
(-) :  Either no data provided or in case of overlap, data included in original study.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
PDGene Recent Updates
PDGene Top Results
PDGene Stats
Studies: 881
Genes: 915
Polymorphisms: 3446
Meta-analyses: 889
PDGene Links
GEO-PD Meeting 2012
PDmutDB
Curated by the VIB Department of Molecular Genetics of the University of Antwerp
Parkinson's disease Mutation Database
Curated by Parkinson's Institute from Leiden University Medical Center
Mutation Database for Parkinson's Disease
Curated by the Institute for Infocomm Research in Singapore
Michael J. Fox Foundation
The PDGene database is supported by a grant from The Michael J. Fox Foundation in partnership with the Alzheimer Research Forum.
PD Online Research
Alzheimer Research Forum
ALSGene
AlzGene
MSGene
PDGene
SZGene
An up-to-date collection of all published genetic association studies.
Copyright © 2014 Biomedical Research Forum LLC Disclaimer Copyright